Occam Crest Management LP

Position in TGTX — Tg Therapeutics, Inc.

CIK 2085909 Darien, CT

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,349,500

+$4,181,560 QoQ

Shares Held

425,000

-26.3% QoQ

Ownership

0.278%

of shares outstanding

% of Portfolio

11.64%

of 13F equity value

Holder Rank

#42

of 426 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Occam Crest Management LP holds $59,155,147 across 5 Biotechnology names. TGTX ranks #1 (39.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TGTX	Tg Therapeutics, Inc. This page	425,000	$23,349,500
2	PGEN	Precigen, Inc.	3,605,941	$20,553,863
3	AXSM	Axsome Therapeutics, Inc.	29,800	$7,294,146
4	NVCT	Nuvectis Pharma, Inc.	357,147	$6,567,933
5	IMRX	Immuneering Corp	278,498	$1,389,705

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,349,500	425,000	-26.3%	Shares	Sole	2026-08-14
2026-03-31	$19,167,940	577,000	+43.7%	Shares	Sole	2026-05-15
2025-12-31	$11,971,546	401,595	-2.0%	Shares	Sole	2026-02-13
2025-09-30	$14,796,619	409,595	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.